- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01746069
Effectiveness of Messages to Mobile Phone in Smoke Cessation
Evaluation of a Reinforcement Program Using Text Messages Through Mobile Phone in Smoking Cessation Programs in Primary Care
Smoking remains a major risk factor for chronic diseases and is a real problem for health systems. The use of emerging technologies, such as mobile phone , may have a important role in smoking cessation programs through sending reinforcement messages when patients quits smoking.
Main objective: To evaluate the effectiveness of a combined 6 months smoking cessation program including health advice provided by a doctor and sending support messages to mobile phone of patients.
Methods: Study design: Randomized single blind clinical trial. Study population: Patients over 18 who are willing to start a smoking cessation program, who have mobile phone, who are able to receive and send messages, and who have a score greater than 5 or equal to 5 on the Richmond scale.
Sample size: 160 patients per arm to detect a difference in the percentage of smoking cessation than 10% (14.9% vs. 4.9%) between the two groups. Intervention: Experimental group: Health advice and support messages to mobile phone patients.
Control group: Health advice. Assessment of the primary endpoint: At 6 months (positive/negative coximetry test).
Statistical analysis: The analysis of the primary endpoint (positive / negative coximetry test) will be performed using logistic regression.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alava
-
Vitoria-Gasteiz, Alava, Spain, 01009
- Health centre Lakuabizkarra
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 18 years.
- Current smoker (25): Current smoker is defined as the person who at the time of the study beginning declares that smoked daily or occasionally.
- Possessing mobile phone.
- Able to receive and send messages through mobile phone.
- Score greater than 5 or equal to 5 on the Richmond scale
Exclusion criteria:
- People with a history of mental and behavioral disorders.
- Patients with a diagnosis of depression using the depression subscale of Goldberg (two or more positive responses).
- Patients who with pharmacological therapy for smoking cessation or who require it throughout the study.
- Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: health advice
clinical practice routine
|
routine clinical practice
|
Experimental: Quit smoking combined cessation programme
Health advice and support sms messages to patient's mobile phone + clinical routine practice
|
Support sms messages to patient's mobile phone and health advice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Coximetry test (positive/negative)
Time Frame: at 6 months
|
at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Continuous abstinence at 6 months: Yes / No
Time Frame: At 6 months
|
Continuous Abstinence is defined as smoking more than 5 cigarettes since the beginning of the follow-up period self-reported by the patient.
|
At 6 months
|
Abstinence point during the first 7 days self-reported by the patient: Yes / No.
Time Frame: at first week
|
Abstinence is defined as not smoking anything punctual during the last seven days.
|
at first week
|
-Prevalence abstinence at the 4th week self-reported by the patient: Yes / No.
Time Frame: At 4th week
|
At 4th week
|
|
-Prevalence abstinence at 12th week self-reported by the patient: Yes / No.
Time Frame: At 12th week
|
At 12th week
|
|
-Outcome of coxymetry test at 12 months of start: Positive / Negative.
Time Frame: at 12 months
|
Only in patients with a negative result in the 6 months test
|
at 12 months
|
Number of messages requested by the patient anxiety.
Time Frame: at 12 months
|
at 12 months
|
|
slip: Yes / No.
Time Frame: at 12 months
|
Treated as the first use (consumption point) after a period of abstinence
|
at 12 months
|
- Relapse: Yes / No.
Time Frame: At 12 months
|
Relapse is defined to return dependent behavior that had tried to change, recovering or not the baseline levels before treatment.
|
At 12 months
|
Number of messages relapse-slip timely requested by the patient.
Time Frame: At 12 months
|
At 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
other variables
Time Frame: at baseline
|
Sex (male / female), age (years), number of cigarettes per day before starting program, age of start smoking (years), smoke related pathology (Yes/No), score on the anxiety scale Goldberg, previous attempts to quit smoking (Yes / No if yes, specify number of attempts and reasons for relapse), ), smoking dependence fagerström test score), type of smoker (occasional / daily).
|
at baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TAB-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityRecruitingSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on health advice
-
Basque Health ServiceUnknownObesity | OverweightSpain
-
King's College LondonPublic Health England; National Institute for Health Research, United KingdomCompletedHealth Behavior | Pollution; ExposureUnited Kingdom
-
University of LiverpoolCompleted
-
Stanford UniversityAllegheny Singer Research Institute (also known as Allegheny Health Network... and other collaboratorsRecruitingDepression | Sleep | Anxiety | Chronic Disease | Mental Health Wellness 1 | Risk Reduction | Physical InactivityUnited States
-
The University of Hong KongHong Kong Council on Smoking and HealthActive, not recruiting
-
Karolinska InstitutetUniversity Hospital, Toulouse; University of Eastern Finland; Universität des...CompletedAlzheimer Disease; ProdromalSweden
-
TNOVitas; SwissAnalysisCompletedDiabetes Mellitus, Type 2Netherlands
-
University of Missouri, Kansas CityNational Cancer Institute (NCI)CompletedSmoking | Tobacco Use | Nicotine DependenceUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DrinkingUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); United States Department of Defense and other collaboratorsRecruitingBreast Cancer | Breast Cancer Screening | Breast Carcinoma in SituUnited States